ABT
57
3
PSX
29
4
DIS
73
-2
DUK
60
5
BK
63
2
VRSK
56
16
SE
65
5
AIG
32
-3
ADI
62
5
PWR
54
-3
KMB
28
-2
UNM
63
-2
KMX
47
7
ADP
66
4
SO
55
13
PHM
43
6
VRTX
49
3
MKC
53
2
HD
37
2
WEC
48
7
ABT
57
3
PSX
29
4
DIS
73
-2
DUK
60
5
BK
63
2
VRSK
56
16
SE
65
5
AIG
32
-3
ADI
62
5
PWR
54
-3
KMB
28
-2
UNM
63
-2
KMX
47
7
ADP
66
4
SO
55
13
PHM
43
6
VRTX
49
3
MKC
53
2
HD
37
2
WEC
48
7
Financhill
Back

Invesco S&P Ultra Dividend Revenue ETF Vs. Collegium Pharmaceutical Industry Stock Comparison

Sell
23

RDIV
Invesco S&P Ultra Dividend Revenue ETF

Last Price:
$48.09
Seasonality Move:
-0.32%
Sell
45

COLL
Collegium Pharmaceutical

Last Price:
$33.33
Seasonality Move:
-1.63%
Sell
23
Invesco S&P Ultra Dividend Revenue ETF (RDIV) is a Sell

Is Invesco S&P Ultra Dividend Revenue ETF a Buy, Sell or Hold?

  • The current Invesco S&P Ultra Dividend Revenue ETF [RDIV] share price is $48.30. The Score for RDIV is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RDIV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Collegium Pharmaceutical (COLL) is a Sell

Is Collegium Pharmaceutical a Buy, Sell or Hold?

  • The current Collegium Pharmaceutical [COLL] share price is $33.34. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RDIV Stock Price Chart

What is Invesco S&P Ultra Dividend Revenue ETF's stock price today?

  • The Invesco S&P Ultra Dividend Revenue ETF share price today is $48.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RDIV is experiencing buying pressure, which is a positive indicator for future bullish movement.

COLL Stock Price Chart

What is Collegium Pharmaceutical's stock price today?

  • The Collegium Pharmaceutical share price today is $33.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.

RDIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 36.07 Sell
Chaikin Money Flow: 25994 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.22 - 51) Sell
Bollinger Bands (100): (48.65 - 51.05) Sell

COLL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 66.05 Buy
Chaikin Money Flow: 1007158 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.9 - 30.94) Buy
Bollinger Bands (100): (30.52 - 37.92) Sell

RDIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.3 Buy
20-day SMA: 49.08 Sell
50-day SMA: 50.28 Sell
200-day SMA: 47.65 Buy
8-day EMA: 48.4 Sell
20-day EMA: 49.05 Sell
50-day EMA: 49.71 Sell
200-day EMA: 47.78 Buy

COLL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.45 Buy
20-day SMA: 29.79 Buy
50-day SMA: 30.91 Buy
200-day SMA: 34.47 Sell
8-day EMA: 30.02 Buy
20-day EMA: 29.94 Buy
50-day EMA: 31.21 Buy
200-day EMA: 32.94 Buy

Invesco S&P Ultra Dividend Revenue ETF Earnings Growth & RDIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.51 per share.

Invesco S&P Ultra Dividend Revenue ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Collegium Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):